News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Iovance Biotherapeutics, Inc. - Common Stock
(NQ:
IOVA
)
4.910
-0.090 (-1.80%)
Streaming Delayed Price
Updated: 11:37 AM EDT, Jul 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Iovance Biotherapeutics, Inc. - Common Stock
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
23
24
Next >
Iovance Biotherapeutics to Present at Upcoming Conferences
March 01, 2024
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
(IOVA) - Analyzing Iovance Biotherapeutics's Short Interest
↗
March 01, 2024
Via
Benzinga
Why Iovance Biotherapeutics Stock Got Trounced on Thursday
↗
February 29, 2024
A robust rally ended abruptly with the publication of the company's latest fundamentals.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
↗
February 29, 2024
Via
Benzinga
Spotlight on Iovance Biotherapeutics: Analyzing the Surge in Options Activity
↗
February 29, 2024
Via
Benzinga
Iovance Biotherapeutics: Q4 Earnings Insights
↗
February 28, 2024
Via
Benzinga
Iovance Biotherapeutics's Earnings: A Preview
↗
February 27, 2024
Via
Benzinga
Is Iovance a Buy After Its First Regulatory Win?
↗
February 25, 2024
Iovance Biotherapeutics has found a new way to treat cancer.
Via
The Motley Fool
Unpacking the Latest Options Trading Trends in Iovance Biotherapeutics
↗
February 23, 2024
Via
Benzinga
Iovance Therapeutics Stock Has Skyrocketed Over 100% so Far This Year. Is It Still a Buy?
↗
February 29, 2024
More gains might be on the way for this high-flying biotech stock.
Via
The Motley Fool
Iovance Biotherapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates
February 28, 2024
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
3 Stocks Flashing Recent Insider Buying Signals
↗
February 27, 2024
One way to spot an opportunity is by paying attention to insider buying stocks. After all, it’s the insiders that know their company.
Via
InvestorPlace
3 Under-the-Radar Biotech Stocks With Upcoming Catalysts in 2024
↗
February 26, 2024
Find out which under-the-radar biotech stocks have major catalysts on the horizon, and unlock their explosive growth potential.
Via
InvestorPlace
1 Soaring Growth Stock That Could Rise Another 53%, According to Wall Street
↗
February 26, 2024
A successful launch of its first approved therapy could push shares of this innovative new cancer drug developer through the roof.
Via
The Motley Fool
Iovance Biotherapeutics Unusual Options Activity For February 22
↗
February 22, 2024
Via
Benzinga
Why Iovance Biotherapeutics Stock Is Skyrocketing Today
↗
February 20, 2024
Iovance is no longer a clinical-stage biotech.
Via
The Motley Fool
This Biotech Stock Has 47% Upside, According to 1 Wall Street Analyst
↗
February 23, 2024
It has good news in hand and plenty of room to grow.
Via
The Motley Fool
2 Top Biotech Stocks That Wall Street Thinks Could Soon Double in Value
↗
February 23, 2024
These two businesses have viable paths to making investors richer -- possibly soon.
Via
The Motley Fool
Iovance Biotherapeutics to Host Fourth Quarter and Full-Year 2023 Financial Results Conference Call and Webcast on Wednesday, February 28, 2024
February 22, 2024
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
MAIA Biotechnology: Undervalued With Eye-Popping Cancer Data And Partnership Potential
↗
February 22, 2024
MAIA Biotechnology, a biotechnology company developing innovative cancer treatments, has seen its stock drift downwards for the past months.
Via
Talk Markets
Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
February 21, 2024
Shares of International Flavors & Fragrances Inc. (NYSE: IFF) fell during Wednesday’s session after the company reported mixed fourth-quarter financial results and reduced its expected quarterly...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
February 21, 2024
Via
Benzinga
Iovance Biotherapeutics Inc. (NASDAQ: IOVA) Near Top of Volume Charts in Wednesday Trading
February 21, 2024
Via
Investor Brand Network
Toll Brothers Posts Upbeat Earnings, Joins Exelon, Garmin, Bausch + Lomb And Other Big Stocks Moving Higher On Wednesday
↗
February 21, 2024
U.S. stocks were lower, with the Nasdaq Composite falling more than 100 points on Wednesday.
Via
Benzinga
Topics
Stocks
Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
February 20, 2024
Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results.
Via
Benzinga
Why Is Iovance Therapeutics (IOVA) Stock Up 35% Today?
↗
February 20, 2024
With Iovance Therapeutics gaining FDA approval for its novel skin cancer therapeutic, IOVA stock is proving the bears wrong.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
February 20, 2024
Via
Benzinga
Iovance Biotherapeutics Inc. (NASDAQ: IOVA) Near Top of Volume Charts in Tuesday Trading
February 20, 2024
Via
Investor Brand Network
Walmart Posts Upbeat Earnings, Joins Armstrong World Industries, Owens & Minor And Other Big Stocks Moving Higher On Tuesday
↗
February 20, 2024
U.S. stocks were mostly lower, with the Nasdaq Composite falling more than 200 points on Tuesday.
Via
Benzinga
Topics
Stocks
What's Going On With Iovance Biotherapeutics Stock?
↗
February 20, 2024
Iovance Biotherapeutics announced Tuesday that the U.S. Food and Drug Administration (FDA) approved the company to begin analytical testing and manufacturing of AMTAGVI at its Philadelphia site....
Via
Benzinga
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
23
24
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
